Two Sigma Investments, LP Aeglea Bio Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.61 $21,210 - $44,615	-73,140 Reduced 18.58%	320,498 $92,000
Q4 2022 Feb 14, 2023	BUY	$0.35 - $1.54 $101,517 - $446,675	290,049 Added 280.0%	393,638 $177,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.81 $80,655 - $171,923	-212,251 Reduced 67.2%	103,589 $54,000
Q2 2022 Aug 15, 2022	BUY	$0.5 - $2.66 $49,619 - $263,975	99,239 Added 45.82%	315,840 $160,000
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $284,408 - $725,469	152,090 Added 235.76%	216,601 $498,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $225,788 - $543,182	64,511 New	64,511 $306,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $115,858 - $153,622	-18,332 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $310,493 - $393,628	-45,931 Reduced 71.47%	18,332 $145,000
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $537,093 - $752,083	-76,509 Reduced 54.35%	64,263 $506,000
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $379,825 - $544,358	58,345 Added 70.78%	140,772 $998,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $188,494 - $518,946	47,006 Added 132.71%	82,427 $762,000
Q1 2020 May 15, 2020	SELL	$3.51 - $8.48 $49,845 - $120,424	-14,201 Reduced 28.62%	35,421 $165,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $8.55 $358,767 - $424,268	49,622 New	49,622 $379,000
Q3 2019 Nov 14, 2019	SELL	$6.42 - $9.0 $317,520 - $445,122	-49,458 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $301,693 - $434,241	49,458 New	49,458 $339,000
Q4 2018 Feb 14, 2019	SELL	$6.51 - $10.19 $171,746 - $268,832	-26,382 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$8.24 - $11.0 $99,094 - $132,286	-12,026 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $94,644 - $130,963	12,026 New	12,026 $127,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account